RANI
- Rani Therapeutics Holdings, Inc.
()
Overview
Company Summary
Rani Therapeutics Holdings, Inc. (RANI) is a biotechnology company that specializes in developing innovative medical solutions. Their primary focus is on transforming oral drugs into injectable-like drugs, leveraging their proprietary RaniPillTM technology.
The RaniPillTM technology is a unique approach that allows drugs to be delivered orally without being degraded by the body's digestive system. Typically, most drugs need to be injected to bypass the stomach's harsh environment and ensure effective absorption. However, Rani Therapeutics has developed a pill that, once swallowed, can safely traverse the digestive system and deliver the drug into the bloodstream in a manner similar to an injection.
By converting injectable drugs into oral form, Rani Therapeutics aims to offer patients a more convenient and comfortable alternative to injections. This technology has the potential to revolutionize the treatment of various diseases by enabling oral delivery of drugs that were previously only available through injections.
Rani Therapeutics focuses on diseases that require chronic administration of drugs, such as diabetes, autoimmune disorders, and hormonal therapies. Their technology has the potential to improve patient compliance and quality of life by eliminating the need for regular injections.
As a company, Rani Therapeutics collaborates with pharmaceutical and biotechnology partners to develop and license their technology for various drugs. They work on preclinical and clinical research, manufacturing, and commercialization strategies to bring their innovative oral delivery system into the market.
Overall, Rani Therapeutics is dedicated to transforming the way drugs are delivered, providing a more patient-friendly approach that enhances convenience, improves compliance, and potentially opens new treatment options for a wide range of medical conditions.